Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
35.6M
-
Shares change
-
-839K
-
Total reported value, excl. options
-
$677M
-
Value change
-
-$16.1M
-
Put/Call ratio
-
0
-
Number of buys
-
74
-
Number of sells
-
-62
-
Price
-
$19.05
Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q3 2022
169 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q3 2022.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35.6M shares
of 38M outstanding shares and own 93.66% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.42M shares), BlackRock Inc. (4.32M shares), MPM ASSET MANAGEMENT LLC (2.74M shares), BOXER CAPITAL, LLC (2.15M shares), STATE STREET CORP (2.11M shares), BVF INC/IL (1.81M shares), VANGUARD GROUP INC (1.75M shares), BIOIMPACT CAPITAL LLC (1.75M shares), CITADEL ADVISORS LLC (1.32M shares), and TANG CAPITAL MANAGEMENT LLC (938K shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.